TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04188288

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental feedback
Description: Participants provided with feedback of target brain activation patterns (for example, in the form of a line graph) and will be instructed to try to make the line go up or down.

Intervention type: DEVICE
Group type: OTHER
Intervention: Control feedback
Description: Participants provided with control type of feedback (for example, in the form of a line graph) and will be instructed to try to make the line go up or down.

Intervention type: DEVICE
Group type: OTHER
Intervention: fMRI
Description: fMRI will be used to assess brain activity

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: fMRI
Description: fMRI will be used to assess brain activity
Study: NCT06209060

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hammock Position
Description: Researchers will make a hammock by using a soft rectangular cotton cloth with ropes that pass through the circular openings of the incubator and are tied on the upper part of it. Babies will be placed in this hammock in a supine position with their extremities in the midline. The spine of the preterm neonate will support while arms and knees are flexed. Additionally, a small rectangular roller will be placed between the cervical and scapular region of the newborn in the hammock position to ensure that no hyperflexion or hyperextension position of the head occurs, which may impair respiratory function.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nesting
Description: In the nesting group, a nest will be made using rolls prepared with materials such as towels and blankets, and the baby will be placed in this nest. The baby's head and body will be positioned on the same axis, its extremities will be positioned in the midline, and its hands will be positioned close to its face.
Study: NCT06630624

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IP-001
Description: Intra-tumoral injection of IP-001 following ablation (RFA, MWA or IRE).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IP-001
Description: Intra-tumoral injection of IP-001 following ablation (RFA, MWA or IRE).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IP-001
Description: Intra-tumoral injection of IP-001 following ablation (RFA, MWA or IRE).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IP-001
Description: Intra-tumoral injection of IP-001 following ablation (RFA, MWA or IRE).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IP-001
Description: Intra-tumoral injection of IP-001 following ablation (RFA, MWA or IRE).
Study: NCT06629870

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: virtual reality
Description: patients who received distraction using virtual reality glasses

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: control group
Description: no any anxiety-reducing application

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: hypnotherapy
Description: patients receiving hypnotherapy

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: mindfulness
Description: patients who underwent mindfulness-based meditation
Study: NCT06555367

Intervention type: DEVICE
Intervention: scleral lenses
Description: Wear scleral lenses
Study: NCT05103657

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1358894
Description: BI 1358894

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT05920187

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mediterranean diet and Anti-inflammatory diet
Description: Cases will be randomly allocated to two groups: Mediterranean diet group (following dietary intervention based on MD), and Anti_inflammatory diet group(following dietary intervention based on IBD-AIF). Patients of the control group will not be instructed to follow a specific dietary intervention.~Evaluation of adherence of cases to dietary intervention will be at two points of time: after four weeks and after 12 weeks by using Mediterranean Diet Serving Score (MDSS) for MD adherence and Anti- Inflammatory Diet Serving Score for IBD- AID adherence. The AID Serving Score (AIDSS) is based on the latest update of the Anti-Inflammatory Diet Pyramid, using the recommended consumption frequency of foods and food group.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mediterranean diet and Anti-inflammatory diet
Description: Cases will be randomly allocated to two groups: Mediterranean diet group (following dietary intervention based on MD), and Anti_inflammatory diet group(following dietary intervention based on IBD-AIF). Patients of the control group will not be instructed to follow a specific dietary intervention.~Evaluation of adherence of cases to dietary intervention will be at two points of time: after four weeks and after 12 weeks by using Mediterranean Diet Serving Score (MDSS) for MD adherence and Anti- Inflammatory Diet Serving Score for IBD- AID adherence. The AID Serving Score (AIDSS) is based on the latest update of the Anti-Inflammatory Diet Pyramid, using the recommended consumption frequency of foods and food group.
Study: NCT06163521

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education
Description: A training consisting of 8 sessions of 40 minutes each will be applied to the children. One session will be done every week. The training will consist of activities including information, discussion and role-playing about children with special needs. The training topics consist of; Children with Special Needs Empathy Differences, Respect for Differences Contact Activity Awareness Benevolence Social Acceptance and Behaviour What can we do?
Study: NCT04622527

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Random assigned paradigm viewing order
Description: Participants experience the paradigm in a random order
Study: NCT04776356

Intervention type: DEVICE
Intervention: QuickFix Small Staple (Arthrex)
Description: The Arthrex QuickFix Small Staple enables the surgeon to perform a wedge osteotomy of the first phalanx (Akin). The device is made of stainless steel and designed with barbed leg tips. The staple sizes are 8 and 10 mm wide with a 1 mm diameter.
Study: NCT04622527

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Random assigned paradigm viewing order
Description: Participants experience the paradigm in a random order

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Random assigned paradigm viewing order
Description: Participants experience the paradigm in a random order
Study: NCT04622527

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Random assigned paradigm viewing order
Description: Participants experience the paradigm in a random order
Study: NCT06018519

Intervention type: OTHER
Group type: OTHER
Intervention: Quality of life scale
Description: 18- Quality of life scale (PedsQL 4.0 for children or San Martin scale if the patient is older than 18)

Intervention type: OTHER
Group type: OTHER
Intervention: Cognitive assessments
Description: 19- Leiter 3 scale (4 cognitive sub-tests to be able to compute the non-verbal IQ and 2 non-verbal memory sub-tests) or Bayley 4 if Leiter 3 is not possible~20- CPM-BF~21- Simple reasoning task on tablet (match-to-sample task)~22- Implicit rules learning (modified Brixton),~23- 4 sub-tests from the WPPSI-IV (zoo location to assess spatial memory, block design to assess visuo-constructive abilities, bug search , cancellation),~24- Attention assessment (4 sub-tests from KITTAP: alert, go/no go, flexibility, divided attention),~25- Elementary visuo-spatial perception (on tablets)
Study: NCT05471167

Intervention type: BIOLOGICAL
Intervention: BCG
Description: Exposure is defined as having received the BCG vaccine during the first year of life.

Intervention type: BIOLOGICAL
Intervention: BCG
Description: Exposure is defined as having received the BCG vaccine during the first year of life.

Intervention type: BIOLOGICAL
Intervention: BCG
Description: Exposure is defined as having received the BCG vaccine during the first year of life.

Intervention type: BIOLOGICAL
Intervention: BCG
Description: Exposure is defined as having received the BCG vaccine during the first year of life.
Study: NCT06293365

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 1ml PFS
Description: Solution for injection.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 1ml PFS
Description: Solution for injection.
Study: NCT05471167

Intervention type: BIOLOGICAL
Intervention: BCG
Description: Exposure is defined as having received the BCG vaccine during the first year of life.

Intervention type: BIOLOGICAL
Intervention: BCG
Description: Exposure is defined as having received the BCG vaccine during the first year of life.
Study: NCT06293365

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 1ml PFS
Description: Solution for injection.
Study: NCT06018519

Intervention type: OTHER
Group type: OTHER
Intervention: Language assessments
Description: 26- EXALANG 3-6 (10 sub-tests testing for expressive and receptive language assessments),~27- PPVT-5 (receptive vocabulary), EVT-3 (expressive vocabulary),~28- Automatic language analysis (during a 10 minutes interaction, play).

Intervention type: OTHER
Group type: OTHER
Intervention: Language assessments
Description: 26- EXALANG 3-6 (10 sub-tests testing for expressive and receptive language assessments),~27- PPVT-5 (receptive vocabulary), EVT-3 (expressive vocabulary),~28- Automatic language analysis (during a 10 minutes interaction, play).
Study: NCT06293365

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 1ml PFS
Description: Solution for injection.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 1ml PFS
Description: Solution for injection.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 1ml PFS
Description: Solution for injection.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 1ml PFS
Description: Solution for injection.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 1ml PFS
Description: Solution for injection.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 1ml PFS
Description: Solution for injection.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 1ml PFS
Description: Solution for injection.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 2 ml PFS
Description: Solution for injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 2 ml PFS
Description: Solution for injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 2 ml PFS
Description: Solution for injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 2 ml PFS
Description: Solution for injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 2 ml PFS
Description: Solution for injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 2 ml PFS
Description: Solution for injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 2ml AI
Description: Solution for injection.
Study: NCT06018519

Intervention type: OTHER
Group type: OTHER
Intervention: Language assessments
Description: 26- EXALANG 3-6 (10 sub-tests testing for expressive and receptive language assessments),~27- PPVT-5 (receptive vocabulary), EVT-3 (expressive vocabulary),~28- Automatic language analysis (during a 10 minutes interaction, play).

Intervention type: OTHER
Group type: OTHER
Intervention: Language assessments
Description: 26- EXALANG 3-6 (10 sub-tests testing for expressive and receptive language assessments),~27- PPVT-5 (receptive vocabulary), EVT-3 (expressive vocabulary),~28- Automatic language analysis (during a 10 minutes interaction, play).

Intervention type: OTHER
Group type: OTHER
Intervention: Language assessments
Description: 26- EXALANG 3-6 (10 sub-tests testing for expressive and receptive language assessments),~27- PPVT-5 (receptive vocabulary), EVT-3 (expressive vocabulary),~28- Automatic language analysis (during a 10 minutes interaction, play).

Intervention type: OTHER
Group type: OTHER
Intervention: Motor assessments
Description: 29- Kinematic task (specifically designed),~30- Purdue-Pegboard test,~31- Renzi test

Intervention type: OTHER
Group type: OTHER
Intervention: Motor assessments
Description: 29- Kinematic task (specifically designed),~30- Purdue-Pegboard test,~31- Renzi test

Intervention type: OTHER
Group type: OTHER
Intervention: Motor assessments
Description: 29- Kinematic task (specifically designed),~30- Purdue-Pegboard test,~31- Renzi test

Intervention type: OTHER
Group type: OTHER
Intervention: Motor assessments
Description: 29- Kinematic task (specifically designed),~30- Purdue-Pegboard test,~31- Renzi test

Intervention type: OTHER
Group type: OTHER
Intervention: Motor assessments
Description: 29- Kinematic task (specifically designed),~30- Purdue-Pegboard test,~31- Renzi test
Study: NCT06293365

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VAY736 2ml AI
Description: Solution for injection.
Study: NCT06018519

Intervention type: OTHER
Group type: OTHER
Intervention: Motor assessments
Description: 29- Kinematic task (specifically designed),~30- Purdue-Pegboard test,~31- Renzi test

Intervention type: OTHER
Group type: OTHER
Intervention: Motor assessments
Description: 29- Kinematic task (specifically designed),~30- Purdue-Pegboard test,~31- Renzi test
Study: NCT06018519

Intervention type: OTHER
Group type: OTHER
Intervention: Social assessments
Description: 32- Eye-tracking analysis of social visual scenes and social preference index (movies),~33- theory of mind assessment,~34- ADOS scale (Autism Spectrum Disorder),~35- sensitivity to inequality,~36- pro-social behaviors (help of the psychologist)
Study: NCT05569486

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Green Light
Description: This is a low-energy device. It produces almost no heat because it uses an LED source for light. The device does not store energy or electrical power that can be discharged later.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Green Light
Description: This is a low-energy device. It produces almost no heat because it uses an LED source for light. The device does not store energy or electrical power that can be discharged later.
Study: NCT06018519

Intervention type: OTHER
Group type: OTHER
Intervention: Social assessments
Description: 32- Eye-tracking analysis of social visual scenes and social preference index (movies),~33- theory of mind assessment,~34- ADOS scale (Autism Spectrum Disorder),~35- sensitivity to inequality,~36- pro-social behaviors (help of the psychologist)

Intervention type: OTHER
Group type: OTHER
Intervention: Social assessments
Description: 32- Eye-tracking analysis of social visual scenes and social preference index (movies),~33- theory of mind assessment,~34- ADOS scale (Autism Spectrum Disorder),~35- sensitivity to inequality,~36- pro-social behaviors (help of the psychologist)

Intervention type: OTHER
Group type: OTHER
Intervention: Social assessments
Description: 32- Eye-tracking analysis of social visual scenes and social preference index (movies),~33- theory of mind assessment,~34- ADOS scale (Autism Spectrum Disorder),~35- sensitivity to inequality,~36- pro-social behaviors (help of the psychologist)

Intervention type: OTHER
Group type: OTHER
Intervention: Social assessments
Description: 32- Eye-tracking analysis of social visual scenes and social preference index (movies),~33- theory of mind assessment,~34- ADOS scale (Autism Spectrum Disorder),~35- sensitivity to inequality,~36- pro-social behaviors (help of the psychologist)

Intervention type: OTHER
Group type: OTHER
Intervention: Social assessments
Description: 32- Eye-tracking analysis of social visual scenes and social preference index (movies),~33- theory of mind assessment,~34- ADOS scale (Autism Spectrum Disorder),~35- sensitivity to inequality,~36- pro-social behaviors (help of the psychologist)
Study: NCT05560776

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endobronchial ultrasound
Description: Two or three passes per lymph node

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endobronchial ultrasound
Description: Two or three passes per lymph node
Study: NCT05034718

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PIBIS clinical decision support
Description: The intervention is the presence of the PIBIS physician alert and powerform, which is clinical decision support for the treating provider if a patient meets inclusion criteria for Pittsburgh Infant Brain Injury Score (PIBIS) calculation.
Study: NCT06018519

Intervention type: OTHER
Group type: OTHER
Intervention: 3T MRI
Description: 37- Structural, metabolic and functional data

Intervention type: OTHER
Group type: OTHER
Intervention: 3T MRI
Description: 37- Structural, metabolic and functional data

Intervention type: OTHER
Group type: OTHER
Intervention: 3T MRI
Description: 37- Structural, metabolic and functional data

Intervention type: OTHER
Group type: OTHER
Intervention: 3T MRI
Description: 37- Structural, metabolic and functional data

Intervention type: OTHER
Group type: OTHER
Intervention: Cardiac assessments
Description: 38- ECG~39- Ultrasound

Intervention type: OTHER
Group type: OTHER
Intervention: Cardiac assessments
Description: 38- ECG~39- Ultrasound

Intervention type: OTHER
Group type: OTHER
Intervention: Biological collection
Description: 40- Blood sample~41- Urinary sample~42- Superficial skin biopsy

Intervention type: OTHER
Group type: OTHER
Intervention: Biological collection
Description: 40- Blood sample~41- Urinary sample~42- Superficial skin biopsy
Study: NCT05034718

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Standard of care, absent the PIBIS powerform and alert for providers.
Study: NCT05955053

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Midwifery care applied in line with Midwife-Pregnant cooperation
Description: Pregnant women who apply to the obstetrics clinic will be informed about the research by the doctor and the pregnant woman whose labor has started will be sent to the delivery room. The researcher will be welcomed by the midwife from the first time the pregnant woman arrives in labor (delivery room), and firstly she will be informed about the purpose of the research and an informative consent form and a pregnant identification form will be filled in that she agrees to participate in the research. During labor and labor, the research midwife (HYY) will be with a pregnant woman until she gives birth and care will be given according to the items in the midwifery care checklist prepared based on the partnership model. After giving birth to a pregnant woman and applying the scales, another pregnant woman will be transferred and care will be given in the same way according to the midwifery care model checklist.
Study: NCT05782712

Intervention type: BIOLOGICAL
Intervention: adenosine dosage
Description: Whole blood is collected using finger puncture followed by deposit a drop of blood (20 μL) using finnpipette, on a blotting paper (Whatman 903 protein saver cards™) and dried over night at room temperature to obtain dried blood spot (DBS).

Intervention type: BIOLOGICAL
Intervention: adenosine dosage
Description: Whole blood is collected using finger puncture followed by deposit a drop of blood (20 μL) using finnpipette, on a blotting paper (Whatman 903 protein saver cards™) and dried over night at room temperature to obtain dried blood spot (DBS).
Study: NCT06105931

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Hyperinsulinemic-euglycemic clamp
Description: Hyperinsulinemic-euglycemic clamp will be used to assess insulin resistance. After IVs are placed, participants will be transitioned to intravenous insulin administration for the baseline portion of the study. Stable Isotope Tracer Infusions will assess rates of glucose, lipid metabolism, and beta-hydroxybutyrate turnover during the last 30 minutes of the baseline equilibration period and again during the last 30 minutes of the stepped IV insulin infusion periods.
Study: NCT06183502

Intervention type: BEHAVIORAL
Intervention: Quantitative survey
Description: Quantitative surveys will be conducted through Alchemer, a HIPPA-compliant online survey system previously used by our group in collaborative research with CDC and supported by the Emory University Center for AIDS Research (CFAR). Surveys will be optimized for participants to take them through a personal computer, mobile phone, tablet, or the SMART study app. For participants who do not have any of these devices or prefer not to take the survey from their device, each city will have a research space where participants can schedule a convenient time to take the survey on a computer or tablet that the study will provide for that purpose.

Intervention type: PROCEDURE
Intervention: HIV and STI testing
Description: The research team has developed and validated procedures for self-collection of specimens for testing for STIs (syphilis, urethral, rectal, and pharyngeal gonorrhea/chlamydia) and HIV self-testing. All participants will be mailed self-collection kits to provide samples for STIs (urine, rectal swab, and pharyngeal swab for gonorrhea/chlamydia; dried blood spot (DBS) for syphilis testing) and HIV (HIV 4th generation testing on DBS specimens in a CLIA-certified laboratory). Participants will be asked to collect specimens for their STI and HIV testing (every 6 months) and return them to Molecular Testing Labs. For participants who prefer in-person procedures, they will meet study staff who will provide them with the STI and HIV self-collection kit and instructions and provide a room for participants to collect their specimens.

Intervention type: BEHAVIORAL
Intervention: Qualitative Assessment
Description: Focus group discussions (n=up to 48 men for 3 qualitative assessments; total n=up to 144 men) as a part of the study consisting of 9 to 12 focus group discussions (FGD) with an average of 8 (range 3-10) participants in each (3 per city). These focus groups will be conducted once during the first year of the study. FGD will be conducted by a trained moderator using a semi-structured interview guide developed in collaboration with CDC scientists. For the FGD, in each city, there will be one FGD with men who have never used PrEP, one with men who are using PrEP and report no adherence issues, and one with men who are currently using PrEP or used PrEP previously and report sub-optimal adherence. In-Depth Interviews (IDIs) A series of 90 in-depth interviews (same n=up to 45 men for each of 3 qualitative assessments) will be conducted over 18 months: up to 45 IDIs each 6 months apart, with up to 15 IDIs per city each wave.
Study: NCT06105931

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Fat Mixed Meal Tolerance Test
Description: After a 12 hour overnight fast, baseline levels of the lipoproteins will be drawn. The YCCI Bionutrition Service kitchen will prepare the standardized high-fat meal. Participants will administer their bolus insulin per their home regimen for the carbohydrates in the high-fat meal, and then they will consume the meal within a 15-minute timeframe.